A new report from British market research firm Deep Pharma Intelligence provides a profile of the use of artificial intelligence in the drug discovery industry. 17 August 2023
The recent Life Sciences Competitiveness Indicators published by the UK government suggests that international investors are abandoning the country’s life scien 7 August 2023
Bicara Therapeutics, a biotech startup founded in 2021 with the goal of developing dual-action biologics, has appointed David Raben as chief medical officer. 24 July 2023
Venture capital firm Westlake Village BioPartners has announced the launch of its third fund of $450 million to incubate and grow early-stage biotech companies 17 July 2023
Dutch healthcare investor BioGeneration Ventures has closed BVG V, its latest investment fund, securing 150 million euros ($168 million) to support innovative e 14 July 2023
The latest Life Sciences Competitiveness Indicators published by the UK government suggests that international investors are abandoning the country’s life scien 13 July 2023
As interest in advanced therapies continues to surge, a new ophthalmic specialist focused on cell-based medicines has been launched with $70 million in series A 13 July 2023
Boston-based Crossbow Therapeutics, a biotech developing a new class of potent and precise antibody therapies to treat a broad range of cancers, has announced a 12 July 2023
The UK-based non-profit medical research organization and charity LifeArc has announced a program to invest more than £100 million ($127 million) by 2030 to del 6 July 2023
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news
Company Spotlight
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.